Toll Free 1-888-590-9839

  • Modern Veterinary Therapeutics, LLC announces today that the Veterinary Drugs Directorate (VDD) has approved SelavectineTM (selamectin topical solution) in Canada. SelavectineTM, presented in eight dose strengths for dogs and cats of different weights, is a topical parasiticide that provides dogs and cats advanced protection from parasites at an affordable price. Selamectin, the active ingredient in SelavectineTM, is safe, has been used in veterinary medicine for over 20 years, and has the broadest spectrum of antiparasitic efficacy compared to isoxazolines. “Modern Veterinary Therapeutics, LLC is pleased to announce this new approval in Canada which is a monumental expansion of our veterinary product line for small animals,” said Dr. Cuong Tu Ba, President of Modern Veterinary Therapeutics, LLC.